))
This podcast aims to bring you a daily summary of most relevant news in Pharma and BioTech world, fully automated and Generated by ChatGPT. If you're interested in similar podcast checkout www.owith.ai
…
continue reading
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
…
continue reading
Welcome to The Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma, Biotech and Medtech.
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
…
continue reading
News and Analysis of the Biotech and Pharma Industry for Investors and Executives.
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
…
continue reading
CFR Events Audio
…
continue reading
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides ...
…
continue reading
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
…
continue reading
A chance to go inside Council on Foreign Relations events. Listen to world leaders and foreign policy experts discuss and debate the most pressing issues in international affairs.
…
continue reading
Join Hercules Capital in conversations with today’s top CEOs, CFOs, and investors in venture and private equity-backed companies. Learn about their strategies for financing rapid growth and scaling their businesses, as well as their unique interests and life stories that have shaped their paths to success.
…
continue reading
The Prospect Group is a leading global firm specializing in media, research, and consulting. We meet, and discuss the most relevant economic issues with, hundreds of the world’s leading business executives, political elites, and other influential personalities from a cross-section of industries and countries. Watch video interviews from and/or about Malaysia.
…
continue reading
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
…
continue reading
First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO with episodes launching weekly on Tuesday's. 🎧 Stay in the Loop! For the latest news and updates, visit our website: https://vial.com Follow us on social media for real-time insights: Twitter: https://twitter.com/VialTrials LinkedIn: https://www.linkedin.com/company/vialtrials
…
continue reading
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
…
continue reading
In this week’s episode of "The Top Line," Fierce Biotech’s Annalee Armstrong highlights some of the most promising companies that made our prestigious Fierce 15 list back in 2014. A decade later, she revisits these trailblazers to see how they’ve navigated the biotech landscape. To learn more about the topics in this episode: Fierce Biotech's Fierc…
…
continue reading
1
Pharma and Biotech Daily: Navigating Acquisitions, Leadership Changes, and AI Drug Development
3:04
3:04
Play later
Play later
Lists
Like
Liked
3:04
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Edwards recently made two acquisitions totaling $1.2 billion in the heart device sector, while also reporting a slowdown in its core business. Owens & Minor agreed to a $1.36 billion takeover of Rotech to expand its home…
…
continue reading
1
315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves
32:46
32:46
Play later
Play later
Lists
Like
Liked
32:46
What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And is Adam good at math? We discuss all that and more in this week’s episode of “The Readout LOUD,” STAT’s biotech podcast. Tara Bannow, our hospitals and insurance reporter, joins us to talk about a new investigation that shows how UnitedHeal…
…
continue reading
1
In the Know: Pharma, Biotech, and Healthcare Updates
3:11
3:11
Play later
Play later
Lists
Like
Liked
3:11
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.CDRH Director Jeff Shuren is set to step down after 15 years, with Michelle Tarver serving as acting director of the FDA's medical devices unit. Boston Scientific predicts strong growth for Farapulse following a successfu…
…
continue reading
1
Innovating Approaches to Target Diseases of Aging with Jerry McLaughlin, CEO of Life Biosciences
29:30
29:30
Play later
Play later
Lists
Like
Liked
29:30
In this episode, Ayesha spoke with Jerry McLaughlin, chief executive officer and board member of Life Biosciences, a company advancing innovative cellular rejuvenation platforms to reverse diseases of aging. Life Biosciences is developing a gene therapy for primary open-angle glaucoma (POAG) and non-arteritic anterior ischemic optic neuropathy (NAI…
…
continue reading
1
Pharma and Biotech Daily: Navigating the Latest in H5N1, RSV Antibodies, and Biotech Industry Developments
2:06
2:06
Play later
Play later
Lists
Like
Liked
2:06
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The ongoing debate over how countries should handle the H5N1 influenza outbreak is intensifying. U.S. officials have confirmed four cases of livestock-to-human transmission but are not recommending a vaccine push for farm w…
…
continue reading
1
Digital Health Roundup: Brain Talk; Medtronic’s Digital Tech Report OR; UK Guidance
17:15
17:15
Play later
Play later
Lists
Like
Liked
17:15
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights AI discussions at the HLTH Europe conference and an interview with Motif Neurotech's CEO Jacob Robinson. Elizabeth Orr discusses DeepWell DTx's newly launched VR game for treating stress-related hypertension and anxiety. Natasha Barrow provides an overview of Digital M…
…
continue reading
1
Pharma and Biotech Daily: July 22, 2024 Updates
4:02
4:02
Play later
Play later
Lists
Like
Liked
4:02
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Florida has awarded additional Medicaid contracts to CVS, UnitedHealth, and Molina, after they were excluded from the first round of contracts in April. Meanwhile, Steward Health failed to attract qualified bidders during…
…
continue reading
1
Pharma and Biotech Daily: Keeping You Informed on Industry Trends and Developments
3:32
3:32
Play later
Play later
Lists
Like
Liked
3:32
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Mountain Dew introduced the Mountain Dude character in a new campaign called "Do the Dew" created by Goodby Silverstein & Partners. The campaign features a stylish brand character and encourages consumers to get active. A…
…
continue reading
1
Scrip's Five Must-Know Things - 22 July 2024
14:39
14:39
Play later
Play later
Lists
Like
Liked
14:39
Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 July 2024. In this episode: J&J’s Spravato on track for blockbuster status; US uptake of Rezzdifra held up by payers; CNS drugs are surprisingly valuable; obesity rules large cap stocks; and Legend buyout rumors validate China biotech.https://scrip.citel…
…
continue reading
1
Medtech Connect 16: AI For Cross Border Regulation
19:31
19:31
Play later
Play later
Lists
Like
Liked
19:31
In this episode, Medtech Insight senior reporter Hannah Daniel speaks to DJ Fang, chief operating officer and co-founder of Pure Global. Pure Global uses AI to help device manufacturers navigate global regulations, and we talk about clinical trials, how countries incentivize medtech innovation, and the Biden Administration’s tariffs on some Chinese…
…
continue reading
1
Drug Fix Special: Why The US Approves Most New Drugs Before The EU
30:31
30:31
Play later
Play later
Lists
Like
Liked
30:31
Pink Sheet reporter and editors discuss the impact of a US and EU drug approvals analysis that found the US FDA still clears many novel products first, including most new cell and gene therapies and cancer treatments.More On This Topics From The Pink SheetPharma Looks To America First: US FDA Holds Overwhelming Lead Over EMA In Novel Approvals: htt…
…
continue reading
1
Former FTC director weighs in on Novo's $16.5B deal with Catalent
17:18
17:18
Play later
Play later
Lists
Like
Liked
17:18
Back in February, Novo Holdings laid out a $16.5 billion deal to snap up contract manufacturing giant Catalent. In this week's episode of "The Top Line," we dive into the current state and implications of the proposed buyout. Fierce Pharma’s Fraiser Kansteiner is joined by former FTC policy director David Balto. They discuss the likelihood of the d…
…
continue reading
1
314: JD Vance's biotech ties, Cassava resignations, and insulin shortages
33:02
33:02
Play later
Play later
Lists
Like
Liked
33:02
Our Washington correspondent Sarah Owermohle joins us to talk about how JD Vance, Donald Trump's newly announced running mate, could influence health policy if Trump wins the election. We also discuss the latest news in the biopharma industry, including the latest developments in the ongoing controversy surrounding Cassava’s Alzheimer’s drug, short…
…
continue reading
1
#33 - How Corporate Venture Capital is Driving Healthcare Innovation | Vijay Patel
57:04
57:04
Play later
Play later
Lists
Like
Liked
57:04
Vijay Patel is an institutional investor turned corporate venture capitalist. He has spent the last decade at the intersection of finance and healthcare, changing the way CVS Health approaches innovation and strategic investments. His journey from traditional venture capital to leading CVS Health® Ventures has positioned him as a thought leader in …
…
continue reading
1
국내 AI 신약개발, 선진국과 격차 줄이려면? (Korean-language podcast)
3:34
3:34
Play later
Play later
Lists
Like
Liked
3:34
신테카바이오 조해경 사장은 Scrip과의 인터뷰에서 국내 AI 신약 개발 현황을 글로벌 흐름와 비교하고, 국내외 경쟁에서 살아남기 위해 국내업계가 해야 할 일에 대해 이야기했습니다.https://scrip.citeline.com/SC150336/Korea-Looks-To-Close-Gap-In-AI-Drug-Development-CapabilitiesBy Citeline
…
continue reading
1
The Importance of Exploring Genetic Potential
8:29
8:29
Play later
Play later
Lists
Like
Liked
8:29
Discover the key considerations critical to the genetic analysis for advanced therapies, including qPCR and dPCR. Don’t miss expert insights from Chandler Walker, Product Manager of Digital PCR Instruments at Thermo Fisher Scientific and Janelle Hart, managing editor at Citeline.By Citeline
…
continue reading
1
Golden Innovations: Nanocrystal Therapies for ALS and MS with Clene Nanomedicines’ Dr. Karen Ho
34:11
34:11
Play later
Play later
Lists
Like
Liked
34:11
In this episode, Ayesha spoke with Karen S. Ho, PhD, Vice President, Translational Medicine at Clene Nanomedicine, a biopharmaceutical company focused on developing treatments for neurodegenerative diseases to restore and protect neuronal health and function. Clene Nanomedicine is developing nanotherapeutics that target cellular energy impairments …
…
continue reading
1
Scrip's Five Must-Know Things - 16 July 2024
13:43
13:43
Play later
Play later
Lists
Like
Liked
13:43
Audio roundup of selected biopharma industry content from Scrip over the business week ended 12 July 2024. In this episode: Q1’s top 10 drugs; Pfizer’s R&D leadership succession; Lilly bolsters IBD pipeline; first half deal volume up but value down; and EU firms’ China sentiment plummets.https://scrip.citeline.com/SC150587/Quick-Listen-Scrips-Five-…
…
continue reading
1
Find out what to expect from the PDA/FDA Joint Regulatory Conference (Sponsored by Parenteral Drug Association)
13:45
13:45
Play later
Play later
Lists
Like
Liked
13:45
In this episode of The Top Line, sponsored by the Parenteral Drug Association (PDA), we explore the upcoming PDA/FDA Joint Regulatory Conference, happening September 9-11 in Washington, D.C. Our guest, Janeen Skutnik-Wilkinson, Director of Global Quality Regulatory Surveillance and External Engagement for Moderna and Co-Chair of the 33rd annual eve…
…
continue reading
1
EPR Consultant Urges Producers To Start Collecting Packaging Data
16:55
16:55
Play later
Play later
Lists
Like
Liked
16:55
In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials.…
…
continue reading
Pharmaceutical CEOs often earn pay packages worth tens of millions of dollars for leading the top drugmaking companies in the industry. Every year, some new faces enter the rankings while others leave. In this week's episode of "The Top Line," Fierce Pharma’s Eric Sagonowsky and Fraiser Kansteiner discuss Fierce’s annual special report, “Big Pharma…
…
continue reading
1
313: Biotech layoffs, founder-focused VC, & a big pharma exit
34:52
34:52
Play later
Play later
Lists
Like
Liked
34:52
STAT's West Coast biotech reporter Jonathan Wosen joins "The Readout LOUD" to discuss what’s driving workforce cuts. Plus, entrepreneurs Alexis Borisy and Zach Weinberg call in to discuss their biotech incubator Curie.Bio and how they hope to “free the founders.” We also discuss a big change in Pfizer’s leadership and the debate over a new side eff…
…
continue reading
Jay Shambaugh discusses U.S.-China macroeconomic engagement and dialogue with Chinese leadership on overcapacity and economic imbalances.The C. Peter McColough Series on International Economics brings the world's foremost economic policymakers and scholars to address members on current topics in international economics and U.S. monetary policy. Thi…
…
continue reading
Jay Shambaugh discusses U.S.-China macroeconomic engagement and dialogue with Chinese leadership on overcapacity and economic imbalances.The C. Peter McColough Series on International Economics brings the world's foremost economic policymakers and scholars to address members on current topics in international economics and U.S. monetary policy. Thi…
…
continue reading
1
Improving Communication: The Relationship Between Biotech And Biopharma
20:26
20:26
Play later
Play later
Lists
Like
Liked
20:26
Improving Communication: The Relationship Between Biotech And Biopharma by CitelineBy Citeline
…
continue reading
1
From Symptoms to Solutions: Transforming Menopause Treatment with Marci English of Astellas Pharma
28:17
28:17
Play later
Play later
Lists
Like
Liked
28:17
In this episode, Ayesha spoke with Marci English, Vice President and Head of BioPharma Development at Astellas Pharma about a groundbreaking new treatment that addresses the underlying mechanisms of menopause symptoms. In May 2023, Astellas received FDA approval for fezolinetant (commercial name Veozah) for the treatment of moderate to severe vasom…
…
continue reading
CFR experts discuss the results of presidential elections in France and the United Kingdom, as well as what to expect from the 2024 NATO Summit in Washington, DC.
…
continue reading
CFR experts discuss the results of presidential elections in France and the United Kingdom, as well as what to expect from the 2024 NATO Summit in Washington, DC.By Council on Foreign Relations
…
continue reading
Prime Minister Mette Frederiksen of Denmark discusses transatlantic cooperation, Russia's war in Ukraine, and her priorities for the NATO Summit in Washington.By Council on Foreign Relations
…
continue reading
Prime Minister Mette Frederiksen of Denmark discusses transatlantic cooperation, Russia's war in Ukraine, and her priorities for the NATO Summit in Washington.
…
continue reading
1
【3分で解説 世界のファーマ】第19回 FDA「密な面談」を企業に呼び掛け (Japanese-language podcast)
3:37
3:37
Play later
Play later
Lists
Like
Liked
3:37
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「US FDA’s Cell-Gene Therapy Office Head Wants Sponsors To Seek Out Meetings（ 邦題意訳：米国FDAの細胞遺伝子治療室長「もっと面談を」企業に求める理由は）」 （英語版）https://pink.citeline.com/PS154749/US-FDAs-Cell-Gene-Therapy-Office-Head-Wants-Sponsors-To-Seek-Out-Meetings※全文の…
…
continue reading
1
Scrip's Five Must-Know Things - 8 July 2024
15:54
15:54
Play later
Play later
Lists
Like
Liked
15:54
Audio roundup of selected biopharma industry content from Scrip over the business week ended 5 July 2024. In this episode: US approval for Lilly’s Alzheimer's contender; the challenges and rewards of late-stage ADCs; Eisai regains control of ADC from BMS; RSV vaccine developers hit by declining expectations; and an interview with Amgen’s Ian Thomps…
…
continue reading
1
Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead
48:19
48:19
Play later
Play later
Lists
Like
Liked
48:19
Scrip's Joseph Haas, Mandy Jackson and Kevin Grogan discuss the biopharma dealmaking environment as we reach the midpoint of 2024. Haas reviews dealmaking data from the first six months of the year and discusses what experts expect in the months ahead. Jackson and Grogan talk about the industry mood coming out of the annual BIO conference in June a…
…
continue reading
1
Non-Invasive Solutions: Exploring The Role Of Breath Biopsies In Early Detection
25:51
25:51
Play later
Play later
Lists
Like
Liked
25:51
In this episode of the In Vivo podcast, Billy Boyle, CEO of Owlstone Medical, discusses how his company is developing several breath biopsy products for use by clinicians, biopharma companies and researchers.By Citeline
…
continue reading
1
New Frontiers in MASH and Chronic Liver Diseases with Aligos CEO Dr. Lawrence Blatt
34:59
34:59
Play later
Play later
Lists
Like
Liked
34:59
In this episode, Ayesha spoke with Lawrence Blatt, PhD, MBA, Chairman and CEO of Aligos Therapeutics, a company developing targeted therapies for liver diseases like MASH (metabolic dysfunction-associated steatohepatitis) and viral diseases to address important unmet medical needs. Prior to co-founding Aligos Therapeutics, Dr. Blatt served as the G…
…
continue reading
1
In Vivo Podcast Episode with Stefan Woxström
27:02
27:02
Play later
Play later
Lists
Like
Liked
27:02
In Vivo Podcast Episode with Stefan Woxström by CitelineBy Citeline
…
continue reading
1
How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz
47:55
47:55
Play later
Play later
Lists
Like
Liked
47:55
Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and what it is doing to take the brand into the next 125 years, HBW Insight chats with the company’s senior vice president, Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and hea…
…
continue reading
1
Scrip's Five Must-Know Things - 1 July 2024
16:53
16:53
Play later
Play later
Lists
Like
Liked
16:53
Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 June 2024. In this episode: global CEO remuneration; another late-stage loss for Merck KgaA; deals shift to smaller M&A, partnering; Bayer’s Parkinson’s bets bear fruit; and India looks to innovate CAR-T models.https://scrip.citeline.com/SC150517/Quick-L…
…
continue reading
1
Over the Counter: EPR Consultant Urges Producers To Start Collecting Packaging Data
16:55
16:55
Play later
Play later
Lists
Like
Liked
16:55
In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials.…
…
continue reading
1
Drug Fix: What’s In And Out Of US FDA’s Diversity Action Plan Guidance, AI Guidance Also Coming
35:29
35:29
Play later
Play later
Lists
Like
Liked
35:29
Pink Sheet reporter and editors discuss what the FDA included in its long-awaited guidance on clinical trial diversity action plans, along with what was left out (:35), as well as an upcoming guidance on the use of artificial intelligence in regulatory decision-making (27:30).More On These Topics From The Pink SheetDiversity Action Plans Should Be …
…
continue reading
At Fierce Biotech, we love a big M&A deal, but valuation does not always equal the most exciting. In this week's episode of "The Top Line," Fierce Biotech’s Annalee Armstrong and James Waldron discuss what they think are the best and smartest acquisitions in recent years. From obesity to radiopharmaceuticals, they give you the Fierce Biotech team’s…
…
continue reading
The Oscar and BAFTA-nominated Bobi Wine: The People’s President, is set during Uganda’s 2021 presidential election, where music star, activist, and opposition leader Bobi Wine, together with his wife Barbie, rallies supporters in a dangerous fight for freedom from President Museveni’s 35-year regime.Join us for a special screening of the documentar…
…
continue reading
The Oscar and BAFTA-nominated Bobi Wine: The People’s President, is set during Uganda’s 2021 presidential election, where music star, activist, and opposition leader Bobi Wine, together with his wife Barbie, rallies supporters in a dangerous fight for freedom from President Museveni’s 35-year regime.Join us for a special screening of the documentar…
…
continue reading
1
312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate
28:33
28:33
Play later
Play later
Lists
Like
Liked
28:33
STAT health tech reporter Brittany Trang guest co-hosts "The Readout LOUD" this week, where we discuss AI for drug development, the latest in the H5N1 bird flu outbreak, a surprise entrant to the GLP-1 field, and more news in the life sciences. And STAT chief Washington correspondent Rachel Cohrs Zhang joins the podcast to talk about a new proposal…
…
continue reading
1
#32 - The Future of Drug Affordability and Access | Peter Kolchinsky
56:46
56:46
Play later
Play later
Lists
Like
Liked
56:46
In an era where breakthrough innovations coexist with concerns over drug affordability, Peter Kolchinsky, founder and Managing Partner at healthcare and life sciences investment manager RA Capital, joins us to shed light on the factors and paths forward. Hercules Capital's Janice Bourque engages with Peter on his No Patient Left Behind initiative, …
…
continue reading
